Teilen:
Benachrichtigungen
Alles löschen
Themenstarter 19. Dezember 2017 12:37
Revive Therapeutics Ltd. (TSX-V: RVV) (OTCQB: RVVTF) is focused on the research, development and commercialization of novel therapies and technologies for the medical cannabis and cannabinoid pharmaceuticals markets by identifying and investigating potential therapies targeting the endocannabinoid system, such as cannabinoids, that may be repurposed for new indications, be delivered in a different way, combined with existing drugs, or be developed as new chemical entities.
Teilen: